{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:19:43Z","timestamp":1789438783830,"version":"build-2803163510"},"reference-count":104,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bloodreviews.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.blre.2016.08.004","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T10:34:31Z","timestamp":1472812471000},"page":"57-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Placental growth factor: What hematologists need to know"],"prefix":"10.1016","volume":"31","author":[{"given":"Laura F.","family":"Newell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shernan G.","family":"Holtan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2016.08.004_bb0005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nm0206-171","article-title":"Angiogenesis and inflammation face off","volume":"12","author":"Imhof","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.blre.2016.08.004_bb0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nm1351","article-title":"Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation","volume":"12","author":"Fiedler","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.blre.2016.08.004_bb0015","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.it.2006.10.004","article-title":"Angiopoietins: a link between angiogenesis and inflammation","volume":"27","author":"Fiedler","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1016\/j.blre.2016.08.004_bb0020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/cvr\/cvq049","article-title":"Extracellular matrix, inflammation, and the angiogenic response","volume":"86","author":"Arroyo","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.blre.2016.08.004_bb0025","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/j.1349-7006.2007.00633.x","article-title":"Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis","volume":"98","author":"Kimura","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.blre.2016.08.004_bb0030","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/j.1349-7006.2008.00853.x","article-title":"Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy","volume":"99","author":"Ono","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.blre.2016.08.004_bb0035","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1073\/pnas.88.20.9267","article-title":"Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor","volume":"88","author":"Maglione","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2016.08.004_bb0040","doi-asserted-by":"crossref","first-page":"10382","DOI":"10.1074\/jbc.M313237200","article-title":"The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1","volume":"279","author":"Christinger","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2016.08.004_bb0045","doi-asserted-by":"crossref","first-page":"12153","DOI":"10.1074\/jbc.M008055200","article-title":"The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0A resolution","volume":"276","author":"Iyer","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2016.08.004_bb0050","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.1073\/pnas.90.22.10705","article-title":"Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor","volume":"90","author":"Kendall","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2016.08.004_bb0055","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1469-7580.2002.00063.x","article-title":"Soluble flt-1 and the angiopoietins in the development and regulation of placental vasculature","volume":"200","author":"Charnock-Jones","year":"2002","journal-title":"J Anat"},{"key":"10.1016\/j.blre.2016.08.004_bb0060","first-page":"925","article-title":"Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14","volume":"8","author":"Maglione","year":"1993","journal-title":"Oncogene"},{"key":"10.1016\/j.blre.2016.08.004_bb0065","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1006\/bbrc.1997.6813","article-title":"Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing","volume":"235","author":"Cao","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.blre.2016.08.004_bb0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0165-0378(03)00082-2","article-title":"Evidence of a novel isoform of placenta growth factor (PlGF-4) expressed in human trophoblast and endothelial cells","volume":"60","author":"Yang","year":"2003","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.blre.2016.08.004_bb0075","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/08977199308991586","article-title":"A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta","volume":"9","author":"Hauser","year":"1993","journal-title":"Growth Factors"},{"key":"10.1016\/j.blre.2016.08.004_bb0080","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10456-008-9114-4","article-title":"The discovery of the placental growth factor and its role in angiogenesis: a historical review","volume":"11","author":"Ribatti","year":"2008","journal-title":"Angiogenesis"},{"key":"10.1016\/j.blre.2016.08.004_bb0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/08977199709002113","article-title":"Placenta growth factor and vascular endothelial growth factor are co-expressed during early embryonic development","volume":"15","author":"Achen","year":"1997","journal-title":"Growth Factors"},{"key":"10.1016\/j.blre.2016.08.004_bb0090","doi-asserted-by":"crossref","first-page":"35172","DOI":"10.1074\/jbc.274.49.35172","article-title":"Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesis","volume":"274","author":"Yonekura","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2016.08.004_bb0095","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood.V97.7.1968","article-title":"Erythroblasts are a source of angiogenic factors","volume":"97","author":"Tordjman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.004_bb0100","first-page":"1569","article-title":"Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines","volume":"11","author":"Viglietto","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.blre.2016.08.004_bb0105","first-page":"31","article-title":"Structure, expression and receptor-binding properties of placenta growth factor (PlGF)","volume":"237","author":"Persico","year":"1999","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.blre.2016.08.004_bb0110","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1210\/en.2005-0532","article-title":"Modulation of angiogenesis during adipose tissue development in murine models of obesity","volume":"146","author":"Voros","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.blre.2016.08.004_bb0115","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1074\/jbc.271.6.3154","article-title":"Heterodimers of placenta growth factor\/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1\/KDR","volume":"271","author":"Cao","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2016.08.004_bb0120","doi-asserted-by":"crossref","first-page":"25646","DOI":"10.1016\/S0021-9258(18)47298-5","article-title":"Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1\/KDR","volume":"269","author":"Park","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2016.08.004_bb0125","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis","volume":"23","author":"Hicklin","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2016.08.004_bb0130","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011056","article-title":"PlGF: a multitasking cytokine with disease-restricted activity","volume":"2","author":"Dewerchin","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.blre.2016.08.004_bb0135","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nm884","article-title":"Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1","volume":"9","author":"Autiero","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.blre.2016.08.004_bb0140","doi-asserted-by":"crossref","first-page":"re1","DOI":"10.1126\/scisignal.259re1","article-title":"Positive and negative modulation of angiogenesis by VEGFR1 ligands","volume":"2","author":"Cao","year":"2009","journal-title":"Sci Signal"},{"key":"10.1016\/j.blre.2016.08.004_bb0145","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.2337\/diabetes.52.12.2959","article-title":"Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells","volume":"52","author":"Cai","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.blre.2016.08.004_bb0150","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/ATVBAHA.107.158022","article-title":"The molecular basis of VEGFR-1 signal transduction pathways in primary human monocytes","volume":"28","author":"Tchaikovski","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2016.08.004_bb0155","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.exphem.2004.03.005","article-title":"Vascular endothelial growth factor receptor-1 and receptor-2 initiate a phosphatidylinositide 3-kinase-dependent clonogenic response in acute myeloid leukemia cells","volume":"32","author":"List","year":"2004","journal-title":"Exp Hematol"},{"key":"10.1016\/j.blre.2016.08.004_bb0160","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.onc.1201545","article-title":"Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1","volume":"16","author":"Landgren","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.blre.2016.08.004_bb0165","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/sj.bjp.0706347","article-title":"Intracellular pathways triggered by the selective FLT-1-agonist placental growth factor in vascular smooth muscle cells exposed to hypoxia","volume":"146","author":"Bellik","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.blre.2016.08.004_bb0170","first-page":"1207","article-title":"Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis","volume":"61","author":"Hiratsuka","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2016.08.004_bb0175","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2002-11-3423","article-title":"Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor","volume":"102","author":"Selvaraj","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.004_bb0180","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2016.08.004_bb0185","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1600-0412.2011.01186.x","article-title":"A longitudinal study of plasma levels of soluble fms-like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF), sFlt1: PlGF ratio and vascular endothelial growth factor (VEGF-A) in normal pregnancy","volume":"90","author":"Palm","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.blre.2016.08.004_bb0190","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2016.08.004_bb0195","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","article-title":"Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions","volume":"7","author":"Carmeliet","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.blre.2016.08.004_bb0200","doi-asserted-by":"crossref","first-page":"17629","DOI":"10.1074\/jbc.271.30.17629","article-title":"The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis","volume":"271","author":"Clauss","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2016.08.004_bb0205","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1161\/01.RES.0000057997.77714.72","article-title":"VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism","volume":"92","author":"Pipp","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.blre.2016.08.004_bb0210","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nm740","article-title":"Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment","volume":"8","author":"Hattori","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.blre.2016.08.004_bb0215","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","article-title":"VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche","volume":"438","author":"Kaplan","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.blre.2016.08.004_bb0220","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cell.2007.08.038","article-title":"Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels","volume":"131","author":"Fischer","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.blre.2016.08.004_bb0225","first-page":"2011","article-title":"Angiogenesis: a target in solid tumors, also in leukemia?","volume":"2011","author":"Schmidt","year":"2011","journal-title":"Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2016.08.004_bb0230","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cardiores.2004.12.002","article-title":"The biology of vascular endothelial growth factors","volume":"65","author":"Tammela","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.blre.2016.08.004_bb0235","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/jcbfm.2011.167","article-title":"PlGF knockout delays brain vessel growth and maturation upon systemic hypoxic challenge","volume":"32","author":"Freitas-Andrade","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.blre.2016.08.004_bb0240","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/art.24289","article-title":"Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation","volume":"60","author":"Yoo","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.blre.2016.08.004_bb0245","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1365-2249.2000.01097.x","article-title":"Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid","volume":"119","author":"Bottomley","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.blre.2016.08.004_bb0250","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJM199709113371107","article-title":"Pathogenesis and treatment of sickle cell disease","volume":"337","author":"Bunn","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2016.08.004_bb0255","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1182\/blood.V97.6.1584","article-title":"Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation","volume":"97","author":"Belhassen","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.004_bb0260","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11239-005-1377-7","article-title":"Endothelial function in patients with sickle cell anemia during and after sickle cell crises","volume":"19","author":"Blum","year":"2005","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.blre.2016.08.004_bb0265","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease","volume":"293","author":"Rother","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.blre.2016.08.004_bb0270","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4236\/abb.2013.47A1002","article-title":"Cytokine profiles in sickle cell anemia: pathways to be unraveled","volume":"4","author":"Pitanga","year":"2013","journal-title":"Adv Biosci Biotechnol"},{"key":"10.1016\/j.blre.2016.08.004_bb0275","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/mic.11.2.129.151","article-title":"The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy","volume":"11","author":"Hebbel","year":"2004","journal-title":"Microcirculation"},{"key":"10.1016\/j.blre.2016.08.004_bb0280","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2141.2006.06103.x","article-title":"Serum levels of angiogenic factors indicate a pro-angiogenic state in adults with sickle cell disease","volume":"134","author":"Duits","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2016.08.004_bb0285","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1189\/jlb.0708445","article-title":"Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy","volume":"85","author":"Lanaro","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.blre.2016.08.004_bb0290","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1684\/ecn.2013.0328","article-title":"Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition","volume":"24","author":"Keikhaei","year":"2013","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.blre.2016.08.004_bb0295","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1182\/blood-2002-11-3422","article-title":"Placenta growth factor activates monocytes and correlates with sickle cell disease severity","volume":"102","author":"Perelman","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.004_bb0300","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1182\/blood-2007-12-130567","article-title":"Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1 alpha","volume":"112","author":"Patel","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.004_bb0305","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1182\/blood-2009-09-244830","article-title":"High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension","volume":"116","author":"Sundaram","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.004_bb0310","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0022-3476(97)70166-5","article-title":"Airway hyperreactivity in children with sickle cell disease","volume":"131","author":"Leong","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.blre.2016.08.004_bb0315","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/ppul.20716","article-title":"Airway hyperreactivity detected by methacholine challenge in children with sickle cell disease","volume":"42","author":"Ozbek","year":"2007","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.blre.2016.08.004_bb0320","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00408-009-9141-y","article-title":"Pulmonary function and airway hyperresponsiveness in adults with sickle cell disease","volume":"187","author":"Sen","year":"2009","journal-title":"Lung"},{"key":"10.1016\/j.blre.2016.08.004_bb0325","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1182\/blood-2008-07-169821","article-title":"Placenta growth factor induces 5-lipoxygenase-activating protein to increase leukotriene formation in sickle cell disease","volume":"113","author":"Patel","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.004_bb0330","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/bmj.319.7202.90","article-title":"What are leukotrienes and how do they work in asthma?","volume":"319","author":"Berger","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.blre.2016.08.004_bb0335","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1067\/mlc.2002.121200","article-title":"Eicosanoids in sickle cell disease: potential relevance of neutrophil leukotriene B4 to disease pathophysiology","volume":"139","author":"Setty","year":"2002","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.blre.2016.08.004_bb0340","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/ajh.21199","article-title":"Elevated urinary leukotriene E4 levels are associated with hospitalization for pain in children with sickle cell disease","volume":"83","author":"Jennings","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2016.08.004_bb0345","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI77250","article-title":"Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13","volume":"126","author":"Eiymo Mwa Mpollo","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2016.08.004_bb0350","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000178143","article-title":"Increased serum levels of anti-angiogenic factors soluble fms-like tyrosine kinase and soluble endoglin in sickle cell disease","volume":"120","author":"Landburg","year":"2008","journal-title":"Acta Haematol"},{"key":"10.1016\/j.blre.2016.08.004_bb0355","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2141.2010.08410.x","article-title":"Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell disease","volume":"152","author":"Ataga","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2016.08.004_bb0360","doi-asserted-by":"crossref","first-page":"1392-1392","DOI":"10.1182\/blood.V124.21.1392.1392","article-title":"Increased von Willebrand factor and high circulating placental growth factor correlate with inflammation and iron overload in patients with compound heterozygous sickle cell and beta-thalassemia","volume":"124","author":"Voskaridou","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.004_bb0365","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2013-11-539718","article-title":"Heme-bound iron activates placenta growth factor in erythroid cells via erythroid Kruppel-like factor","volume":"124","author":"Wang","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.004_bb0370","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1182\/blood.V97.5.1427","article-title":"Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes","volume":"97","author":"Bellamy","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.004_bb0375","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2141.2008.07372.x","article-title":"Antiangiogenesis in haematological malignancies","volume":"143","author":"Li","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2016.08.004_bb0380","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V96.6.2240","article-title":"Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes","volume":"96","author":"Aguayo","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.004_bb0385","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/cncr.10900","article-title":"Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes","volume":"95","author":"Aguayo","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2016.08.004_bb0390","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/152581602753448586","article-title":"Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia","volume":"11","author":"Brunner","year":"2002","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1016\/j.blre.2016.08.004_bb0395","doi-asserted-by":"crossref","first-page":"6978","DOI":"10.1158\/1078-0432.CCR-06-1140","article-title":"Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from Children's Oncology Group Study CCG-1962","volume":"12","author":"Avramis","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.blre.2016.08.004_bb0400","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1182\/blood-2005-06-2530","article-title":"VEGFR-1 (FLT-1) activation modulates acute lymphoblastic leukemia localization and survival within the bone marrow, determining the onset of extramedullary disease","volume":"107","author":"Fragoso","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.004_bb0405","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/sj.leu.2404668","article-title":"VEGF\/PLGF induces leukemia cell migration via P38\/ERK1\/2 kinase pathway, resulting in Rho GTPases activation and caveolae formation","volume":"21","author":"Casalou","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2016.08.004_bb0410","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-0609.2005.00505.x","article-title":"Placenta growth factor stimulates the growth of Philadelphia chromosome positive acute lymphoblastic leukemia cells by both autocrine and paracrine pathways","volume":"75","author":"Ikai","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2016.08.004_bb0415","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ccr.2011.05.007","article-title":"Loss or inhibition of stromal-derived PlGF prolongs survival of mice with imatinib-resistant Bcr-Abl1(+) leukemia","volume":"19","author":"Schmidt","year":"2011","journal-title":"Cancer Cell"},{"issue":"Suppl 2","key":"10.1016\/j.blre.2016.08.004_bb0420","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.3816\/CCC.2004.s.010","article-title":"Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer","volume":"4","author":"Hurwitz","year":"2004","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.blre.2016.08.004_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2710.2007.00800.x","article-title":"Bevacizumab, a humanized anti-angiogenic monoclonal antibody for the treatment of colorectal cancer","volume":"32","author":"Kramer","year":"2007","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.blre.2016.08.004_bb0430","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ccr.2010.11.009","article-title":"HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF","volume":"19","author":"Rolny","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.blre.2016.08.004_bb0435","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1158\/1078-0432.CCR-08-2276","article-title":"\u201cAntimyeloangiogenic\u201d therapy for cancer by inhibiting PlGF","volume":"15","author":"Loges","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.blre.2016.08.004_bb0440","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/bjc.2011.609","article-title":"A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours","volume":"106","author":"Lassen","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.blre.2016.08.004_bb0445","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1634\/stemcells.2006-0020","article-title":"Placental growth factor-1 potentiates hematopoietic progenitor cell mobilization induced by granulocyte colony-stimulating factor in mice and nonhuman primates","volume":"25","author":"Carlo-Stella","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.blre.2016.08.004_bb0450","article-title":"Placental growth factor expression is required for bone marrow endothelial cell support of primitive murine hematopoietic cells","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.blre.2016.08.004_bb0455","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.radonc.2012.10.005","article-title":"Bone marrow transplantation rescues intestinal mucosa after whole body radiation via paracrine mechanisms","volume":"105","author":"Chang","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.blre.2016.08.004_bb0460","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.1171.1171","article-title":"Tissue expression of placental growth factor in acute graft versus host disease after hematopoietic stem cell transplantation","author":"Leonard","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.004_bb0465","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1182\/blood-2005-02-0468","article-title":"The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone","volume":"106","author":"Flomenberg","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.004_bb0470","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.trsl.2008.10.001","article-title":"Placental growth factor attenuates suppression of erythroid colony formation by interferon","volume":"152","author":"Dallalio","year":"2008","journal-title":"Transl Res"},{"key":"10.1016\/j.blre.2016.08.004_bb0475","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1182\/blood-2011-09-378174","article-title":"VEGFR1 stimulates a CXCR4-dependent translocation of megakaryocytes to the vascular niche, enhancing platelet production in mice","volume":"120","author":"Pitchford","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.004_bb0480","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1084\/jem.20050959","article-title":"Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization","volume":"202","author":"Heissig","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2016.08.004_bb0485","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.bbmt.2015.02.018","article-title":"Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from blood and marrow transplant clinical trials network 0302 and 0802","volume":"21","author":"Holtan","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2016.08.004_bb0490","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.bbmt.2015.11.363","article-title":"Angiogenic factors, inflammation, and outcomes in myeloablative allogeneic hematopoietic cell transplantation: a biomarker analysis of GVHD prophylaxis in blood and marrow transplant clinical trials network protocol (BMT CTN) 0402","volume":"22","author":"Newell","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2016.08.004_bb0495","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jdermsci.2009.12.006","article-title":"Histological and transcriptional study of angiogenesis and lymphangiogenesis in uninvolved skin, acute pinpoint lesions and established psoriasis plaques: an approach of vascular development chronology in psoriasis","volume":"57","author":"Henno","year":"2010","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.blre.2016.08.004_bb0500","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1572-0241.2005.40819.x","article-title":"Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease","volume":"100","author":"Kader","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.blre.2016.08.004_bb0505","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bbmt.2014.02.012","article-title":"Late cardiovascular complications after hematopoietic cell transplantation","volume":"20","author":"Chow","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2016.08.004_bb0510","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1161\/CIRCULATIONAHA.104.495887","article-title":"Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation","volume":"111","author":"Khurana","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2016.08.004_bb0515","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1161\/01.CIR.90.2.775","article-title":"Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture","volume":"90","author":"Moreno","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2016.08.004_bb0520","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.clinthera.2014.09.023","article-title":"New approaches for managing preeclampsia: clues from clinical and basic research","volume":"36","author":"George","year":"2014","journal-title":"Clin Ther"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X16300571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X16300571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T16:06:58Z","timestamp":1657210018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X16300571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":104,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0268960X16300571"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2016.08.004","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Placental growth factor: What hematologists need to know","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2016.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}